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High-density lipoprotein 
contribute to G0-G1/S transition in 
Swiss NIH/3T3 fibroblasts
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Sebastiano Banni2, Maria Collu3, Simonetta Accossu1, Clelia Madeddu4, Roberto Serpe4 & 
Barbara Batetta1
High density lipoproteins (HDLs) play a crucial role in removing excess cholesterol from peripheral 
tissues. Although their concentration is lower during conditions of high cell growth rate (cancer and 
infections), their involvement during cell proliferation is not known. To this aim, we investigated 
the replicative cycles in synchronised Swiss 3T3 fibroblasts in different experimental conditions: i) 
contact-inhibited fibroblasts re-entering cell cycle after dilution; ii) scratch-wound assay; iii) serum-
deprived cells induced to re-enter G1 by FCS, HDL or PDGF. Analyses were performed during each 
cell cycle up to quiescence. Cholesterol synthesis increased remarkably during the replicative cycles, 
decreasing only after cells reached confluence. In contrast, cholesteryl ester (CE) synthesis and 
content were high at 24 h after dilution and then decreased steeply in the successive cycles. Flow 
cytometry analysis of DiO-HDL, as well as radiolabeled HDL pulse, demonstrated a significant uptake 
of CE-HDL in 24 h. DiI-HDL uptake, lipid droplets (LDs) and SR-BI immunostaining and expression 
followed the same trend. Addition of HDL or PDGF partially restore the proliferation rate and 
significantly increase SR-BI and pAKT expression in serum-deprived cells. In conclusion, cell transition 
from G0 to G1/S requires CE-HDL uptake, leading to CE-HDL/SR-BI pathway activation and CEs 
increase into LDs.
A high rate of cholesterol synthesis, uptake and esterification in proliferating tissues, accompanied by 
reduction of plasma cholesterol-HDL, has been extensively described during tumour growth1–6. The 
higher requirement of cholesterol has been attributed to its structural and functional properties in cell 
membrane biogenesis, while the elevated content of CEs was mainly ascribed to the fact that membrane 
cholesterol, rather than being delivered to HDL, is preferentially shifted to ER for esterification by ACAT. 
Therefore, cellular accumulation of CE may be considered an additional store to provide cholesterol 
during sustained membrane biogenesis. We have reported that CEM-CCRF, a lymphoblastic cell line 
characterised by high rate of CE synthesis7, further increase their content by obtaining preformed CEs 
from HDL8. Similarly, in a macrophage tumour-like cell line P388D1, the content of CEs and CE-HDL 
uptake, probably mediated by SR-BI protein, was further induced by microbial stimulus9. SR-BI is a 
membrane protein involved in cell cholesterol efflux in peripheral tissues but responsible for CE-HDL 
uptake in specialised organs with high requirement of cholesterol, like adrenal glands and liver. However, 
SR-BI expression has been reported to be elevated in several tumour cell types10,11. For this reason, 
we Hypothesised that the main function of HDL, related to reverse cholesterol transport activity, may 
change when peripheral requirement of cholesterol increases (i.e., infections and tumours) being their 
plasma levels regulated by cell request9. Beside tumours, increase of macrophage-CE has been described 
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in atherosclerotic lesions, but the possibility that these neutral lipids are also controlled during prolifera-
tion of normal cells has been completely neglected. Indeed, the scarcity of studies investigating a possible 
role of CEs in the pathway involved in cell proliferation may be due to the bulk of literature associat-
ing their accumulation with pathological conditions (i.e., cancers and atherosclerosis). We have previ-
ously observed an increase of CE synthesis during the growth of aortic primary smooth muscle cells12. 
Moreover CE content in LDs is elevated in exponentially growing mouse 3T3 fibroblasts, while being 
virtually absent in confluent quiescent cells13. Recently, the HDL receptor SR-BI has been demonstrated 
to activate phosphorylation of the AKT-dependent mitogen signal, suggesting a correlation between 
CE-HDL uptake and the proliferative signaling cascade14–16. It is then reasonable to Hypothesise that 
changes in CEs pathway is present also during normal cell proliferation. For this reason, we investigated 
CE metabolism during the growth of synchronised mouse 3T3 fibroblasts.
Results
Cell cycle distribution and proliferation after contact-inhibition loss. Figure 1 (panel a) repre-
sents the phase distribution of cells at 0, 24, 48, 72 and 96 h after loss of contact-inhibition. At quiescence 
(0 h), most of cells were in G0/G1 (90%), while 5% were at S and G2. At 24 h, cell percentage, increased 
at S and G2 (57 and 7%, respectively), while 36% of cells were in G0/G1. At 48 h, 62% of cells were in 
G0/G1, while 28 and 10% were in S and G2, respectively. At 72 h, most of cells were at G0/G1 (81%), 
whereas the percentages found at S (12%) and G2 (7%) were lower compared to 24 h proliferating cells. 
At 96 h, cell cycle distribution was similar to that found at 0 h. Cell number doubled at 48, 72 and 96 h 
(Fig. 1b), whereas the higher content of total protein at 24 h, compared to 0 h, suggests that cells were 
mainly in G1 rather than G0 phase (Fig. 1c).
CE, TG and cholesterol synthesis after contact-inhibition loss. Figure 2 shows the CE, TG and 
cholesterol synthesis evaluated through all cell cycles from contact inhibition loss up to quiescence. 
The rate of cholesterol esterification (Fig.  2a) was found significantly higher at 18 and 24 h (p < 0.05) 
from contact loss, whereas it was almost absent at 48, 72 and 96 h after dilution. TG synthesis (Fig. 2b) 
demonstrated the same trend as CE synthesis, showing higher values at 18 and 24 h (p < 0.05). Although 
to different extent, cholesterol synthesis (Fig. 2c) was variable during all replicative cell cycles, showing 
the lowest value at 24 h and peaking at 48 h after contact inhibition loss (p < 0.05).
Flow cytometry analysis of DiO-HDL and radiolabeled [14C]-CE-HDL uptake in cycling and 
quiescent fibroblasts. Figure  3a shows the curve distribution of DiO-HDL fluorescence at 24, 48 
and 96 h from cells dilution. As reported in the relative graph the fluorescent signal is significantly higher 
at 24 h compared to the other time points (p < 0.01). Accordingly, as shown in Fig.  3b, radiolabeled 
Figure 1. Cell cycle distribution after contact-inhibition loss. Contact-inhibited 3T3 Swiss mouse 
fibroblasts were diluted at 1.5 × 104cells/cm2 (exponential growth) up to the concentration of about 
4.0 × 104cells/cm2 (stationary growth), and harvested at the indicated times. (a) For FACS analysis, 
experiments were performed as reported in Materials and Methods. Each sample was in triplicate and 
experiments were performed at least twice. Cell cycle distribution is reported as percentage of cells in each 
discrete phase. At each time an aliquot of cells was used for cell count (b) and another aliquot for protein 
determination (c). Data are given as mean ± SE. *p < 0.05 vs all (t-student test, unpaired two-tailed).
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CE-HDL uptake was remarkably higher at 24 h after the contact loss, steeply decreasing at 48 h and 
reaching the lowest value at the resting state after 96 h (p < 0.05).
Figure 2. Cholesteryl ester, trygliceride and cholesterol synthesis after contact-inhibition loss. 
Cholesteryl ester (a), triglyceride (b) and cholesterol (c) synthesis were evaluated at the indicated times after 
diluting cells at exponential growth and followed up to quiescence. Cells were diluted at 1.5 × 104cells/cm2 
(exponential growth) up to the concentration of about 4.0 × 104cells/cm2 (stationary growth). Cells were 
incubated for 4 h in medium containing [14C]-oleate bound to bovine serum albumin (BSA) (CE and TG 
synthesis) or 3 h with 37 KBq/ml of [14C]-sodium acetate (FC synthesis). After incubation, cells were washed 
with ice-cold PBS, and lipids were extracted with cold acetone and separated by TLC and incorporation 
of [14C]-oleate and sodium [14C]-acetate were measured as described in Methods. An aliquot of cell lysate 
was processed for protein content. All data are expressed as the rate of [14C]-oleate or sodium [14C]-acetate 
incorporation into CEs, TGs and FC for μ g of protein, respectively. Each experiment was carried out at 
least twice in triplicate and the results are given as mean ± SE. *p < 0.05 vs all (t-student test, unpaired two-
tailed).
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DiI-HDL uptake, DiI-LDL binding, SR-BI detection and lipid distribution in cycling and qui-
escent fibroblasts. As shown in Fig. 4, CE-HDL uptake was very active at 24 h, while being almost 
absent 48 and 96 h after dilution, as confirmed by image analysis (p < 0.05). The CE-HDL uptake greedi-
ness by proliferating cells was highly evident when compared to quiescent cells (see movies). Conversely, 
LDL binding (Fig.  4) did not show significant differences when compared to the other groups. SR-BI, 
revealed by immunofluorescence, was remarkably higher at 24 h (p < 0.05), progressively decreasing at 
48 and 96 h, following the same trend as for DiI-HDL. Although NR polar lipid (red circles) fluorescence 
did not change over the groups, the image analysis of NR neutral lipids (green squares) showed a higher 
signal at 24 h (p < 0.05) that decreased steeply at the later points. The figure shows also that the plasma 
membrane cholesterol content, demonstrated by filipin staining, was significantly increased at 96 h (blue 
triangles) (p < 0.05).
FC and CE content in 3T3 fibroblasts. HPLC analysis (table  1) revealed that FC content did not 
show significant changes between the two experimental groups. Conversely, the intracellular CE content 
was more than 2-folds higher in 24 h exponentially growing cells compared to quiescent cells (p < 0.05). 
The remarkable increase of CE content affected the total cholesterol (TC) content as well as the CE/TC 
ratio that was significantly higher in diluted cells compared to confluent cells (p < 0.05).
Scratch wound assay. The Fig. 5 shows DiI-HDL uptake, DiI-LDL binding, SR-BI immunostaining 
and neutral lipid content (NR) in proliferating (facing) and quiescent (distant) cells in the same culture 
dish after 24 h from the scratch wound. DiI-HDL uptake was present in cells facing the wound, whereas 
it was largely absent in contact-inhibited cells (distant). DiI-LDL binding was similar in contact-inhibited 
cells and in those facing the wound. SR-BI immunostaining followed the same trend as DiI-HDL, being 
higher in cells in the wound area. Neutral lipids (NR) and resumption of proliferation (BrdU/Hoechst) 
were present in cells facing the wound but were almost absent in distant quiescent contact-inhibited cells.
Cell cycle distribution, SR-BI, pAKT and pERK protein expression in serum-deprived cells 
entering the cycle after 24 h treatment with FCS, HDL or PDGF. Figure  6a depicts the cell 
cycle distribution in 24 h serum-deprived cells treated for 24 h with FCS, HDL or PDGF. As shown 
in the figure, most of serum-deprived cells (SDC) were in G0/G1 (89%), whereas 5 and 6% were in S 
and G2, respectively. At 24 h from treatment with FCS an increase of S and G2 was seen (11 and 14%, 
respectively). Similarly, the percentage of HDL treated cells was increased in S and G2 (both 11%). After 
PDGF treatment, 8% of cells were in S, whereas 11% were in G2. Accordingly, densitometric analysis of 
pAKT protein expression bands (Fig.  6e) detected a significant increase in FCS and HDL treated cells 
(p < 0.05). SR-BI protein expression (Fig.  6c), even if to different extent, was increased following each 
treatment (p < 0.05). No differences were found in pERK protein expression at 24 h (Fig. 6g).
Figure 3. FACS analysis of DiO-HDL fluorescence and radiolabeled cholesteryl [14C]-oleate HDL uptake 
in 24, 48 and 96 h cultured 3T3 Swiss mouse fibroblasts. Panel a: shows the FACS diagram of fluorescence 
signal related to DiO-HDL uptake in 24, 48 and 96 h fibroblasts after contact loss. Cells were incubated with 
DiO-HDL and prepared for FACS analysis as reported in Material and Methods section. Each experiment 
was carried out at least twice and the relative graph shows the weighted mean value ± SE of fluorescence 
evaluated in positive cells (P2) normalized to the entire population (P1 + P2). At least 10000 cells for each 
group were analysed. *p < 0.01 vs 24 h (t-student test, unpaired two-tailed). Panel b: cells were incubated 
with 100 mM [14C]-CE-HDL in LPDS 24 h before the harvesting times. Cells were harvested and lipids 
extracted as described in Material and Methods section. Each experiment was carried out at least twice in 
triplicate and the results are given as mean ± SE. *p < 0.05 vs all (t-student test, unpaired two-tailed).
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Figure 4. DiI-HDL uptake, DiI-LDL binding, SR-BI immunodetection and Nile Red/filipin double 
stain in 24, 48 and 96 h cultured 3T3 Swiss mouse fibroblasts. The figure shows DiI-HDL uptake, DiI-
LDL binding, SR-BI immunocytofluorescence and merged color images obtained by Nile Red/filipin double 
staining, that show polar lipids and cytoplasmic membranes (NR polar lipids) in red, LDs (NR neutral 
lipids) in green/yellow and plasma membrane cholesterol (filipin) in blue. All detections were tested 
on fibroblasts cultured for 24, 48 and 96 h after contact loss in standard medium. Each experiment was 
carried out at least twice and the relative graphs and histograms show the mean values ± SE for each single 
fluorescence emission signal evaluated in at least 200 cells for each group. Bar is 30 μ m. *p < 0.05 vs 24 h; 
°p < 0.05 vs 48 h (ANOVA, Fischer’s LSD as post hoc test).
Treatments FC nmol/107cell CE nmol/107cell TC nmol/107cell CE/CT
CONFLUENT 60.90 192.63 253.46 0.76
DILUTED 60.94 501.96* 564.00* 0.89*
Table 1.  Free cholesterol and cholesteryl ester content in 3T3 fibroblasts. Free cholesterol (FC), 
cholesteryl ester (CE) and total cholesterol (TC), were evaluated in confluent (quiescent) and diluted (24 h 
proliferating) 3T3 Swiss mouse fibroblast cells. *p < 0.05 vs confluent cells (t-student test).
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Figure 5. Scratch wound assay. The figure reports DiI-HDL uptake, DiI-LDL binding, SR-BI 
immunocytofluorescence detection, the merged colour images obtained by Nile Red/filipin double staining, 
that show polar lipids and cytoplasmic membranes in red, LDs in green/yellow and plasma membrane 
cholesterol (filipin) in blue. The figure shows also BrdU (red) incorporated in DNA (Hoechst, blue). All 
detections were performed in distant (quiescent) and facing (proliferating) 3T3 Swiss mouse fibroblasts 
after 24 h from scratch-wound. Each experiment was carried out at least twice and the relative graphs and 
histograms show the mean values ± SE for each single fluorescence emission signal evaluated in at least 200 
cells for each group. Bar is 30 μ m. *p < 0.05 vs distant (ANOVA, Fischer’s LSD as post hoc test).
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Discussion
High CE content, mainly associated with pathological conditions (cancer, infections and atherosclero-
sis), has been related to a high rate of cholesterol esterification and to the reduction of HDL capacity 
in removing peripheral cholesterol17-19. In tumour tissues, this phenomenon has been attributed to the 
need of a continuous supply of cholesterol for membrane biogenesis. Recent studies have demonstrated 
that CEs are directly taken up from HDL in tumour and inflammatory cells, suggesting that HDL, rather 
than removing, may supply CEs to the cells when more CEs are required8,9. Thus, the possibility of a 
more general involvement of CEs in cell growth, in particular CE-HDL, has been scarcely considered, 
Figure 6. Cell cycle distribution, SR-BI, AKT and ERK protein expression in serum-deprived cells 
entering the cell cycle after 24 h treatment with FCS, HDL or PDGF. Sub-confluent cells were cultured for 
24 h in serum-deprived medium (SDC). Then treated for further 24 h with FCS, HDL or PDGF, respectively. 
At the end of experiments cells were harvested and processed as required for cell cycle analysis by FACS 
(a) and western blotting (b), respectively. For details see Materials and Methods. The panel (c–g) show the 
densitometric analysis of SR-BI, AKT, pAKT, ERK and pERK bands, respectively. Data were reported as 
mean ± SE of three different experiments. *p < 0.05 vs SDC; °p < 0.05 vs FCS; ^p < 0.05 vs HDL (ANOVA, 
Fischer’s LSD as post hoc test).
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with CEs metabolism in normal proliferating cells almost completely ignored. In this study, we report 
that the passage of quiescent normal fibroblasts to the replicative cycle presents peculiar modifications 
of CE metabolism, where HDL plays a major role in regulating CE content. These modifications seem to 
be mainly restricted to the passage of cells from G0 to G1/S phases, whereas they are almost absent in 
the following cycles up to the subsequent G0 phase induced by contact-inhibition. Indeed, in the present 
study, flow cytometry analysis of DiO-HDL, definitely shows a significant increase of fluorescent signal 
in 24 h growing compared to the following cycling and resting cells. We obtained similar results when 
cells were incubated with radiolabeled CE-HDL. Accordingly, a remarkable increase in CE synthesis and 
CE-HDL uptake is found 24 h after triggering the passage from G0 to G1/S. These effects were accompa-
nied by a remarkable increase in LDs, even if it is likely that the simultaneous high rate of TG synthesis 
contribute to increase the LD content. Similarly, the amount of the SR-BI membrane protein was found 
increased at the same time. Although this protein generally removes excess cholesterol from peripheral 
cells and delivers it to HDL, its role is devoted to catching preformed CEs in specialised organs (i.e., 
adrenal glands and liver), where storage of cholesterol is needed for hormone or bile acid synthesis20,21. 
However, high expression of this protein has been also described in tumour cells and is thought to be a 
response to the need of FC for membrane biogenesis10,11,22,23. In this study, we demonstrated that fibro-
blasts stimulated to proliferate show an increase of CEs, stored in LDs, obtained from HDL via SR-BI 
but, differently from cancer cells, this phenomenon seems to be restricted to the first cell cycle, and 
disappeared subsequently in G0-G1/S-induced quiescent cells. On the contrary, as reported, cholesterol 
synthesis and LDL binding are present in all replicative cycles up to quiescence24,25. The different route 
undertaken by HDL probably driven by an increased peripheral CE requirements, has been reported in 
tumours and infections and supported by the fact that reduction of CE-HDL precedes the modifications 
of the apoprotein component (i.e. apo A1)26. Differently from in vivo, the in vitro studies did not consent 
to detect nanomolar changes in lipid HDL content but, as shown in the movies attached to this arti-
cle, the CE-HDL uptake is almost absent in quiescent cells, whereas the fluorescent dye is actively and 
quickly internalized in exponentially growing cells. Thus, the count of cell number and FACS analysis 
of cell cycle distribution evaluated at all time points, showed that cells, even if to different extent, were 
still cycling up to 72 h. Similar results were obtained in both ways that we used to sychronise cells in 
G0 phase: (i) contact-inhibition and (ii) the scratch wound method, in which both quiescent (distant) 
and growing cells (facing) can be observed simultaneously in the same culture dish. Also in the latter 
condition, the cells facing the scratch after 24 h were synthesizing DNA, as demonstrated by BrdU nuclei 
staining, and showed a higher content of LDs and CE-HDL uptake, and increased SR-BI immunode-
tection when compared to those distant from the scratch. SR-BI activation has been also involved in 
signal transduction common with proliferation and often associated with increase of the pAKT and 
pERK signal pathway27. In the experiments with synchronised cells for 24 h in serum-deprived medium 
and treated for a further 24 h in the presence of FCS, HDL or PDGF, FACS analysis showed that HDL 
exerted the same mitogenic activity as PDGF although this effect was lower than that exerted by FCS. 
In our experimental conditions, either HDL and PDGF-treated cells, showed a remarkable increase of 
SR-BI protein expression, suggesting that the activation can also be dependent upon the mitogenic stim-
ulus. A mitogenic role of HDL has been reported in different cell lines15,16,22,27. This activity has been 
considered to be mediated by the binding of the lipoprotein with its SR-BI membrane receptor10,11, as 
the binding activates the same proliferative pathway induced by mitogens (i.e. PDGF) such as inducing 
phosphorylation of signal transduction pathways16. However, serum-deprivation followed by addition 
of different mitogens is not the best way to perform this kind of study, because of the small number of 
cycling-induced cells and probably the different effect on the transduction pathway exerted by mitogens. 
In fact, our hypothesis seems to be supported by the fact that SR-BI and pAKT expressions are appar-
ently dependent upon the mitogens used. No difference was found in pERK protein expression in our 
experimental condition but, it is worth noting that these signaling cascade factors should be evaluated 
shortly, after the mitogen signal. Thus, we have concluded that the synchronisation obtained by contact 
inhibition seems more efficient and, at the same time, more similar to physiological condition. We can 
hypothesise that the CE-HDL/SR-BI/LDs pathway may be tightly involved in the mitogenic response 
mainly present during the G0 to G1/S transition, being almost absent in the subsequent cell cycles. On 
the contrary, studies conducted in tumour cells demonstrated that the increase of SR-BI protein expres-
sion is evident during all replicative cycles. In previous studies, we have observed an increased rate 
of cholesterol esterification and CE accumulation in proliferating liver induced with lead nitrate or in 
response to partial hepatectomy28. A notable increase of CEs accompanied by a consistent reduction of 
HDL was evident mainly in the first round cycle (24–48 h). In contrast, cholesterol and DNA synthesis 
were present up to the recovery of the liver size (about 1 week). Despite the intense research on HDL 
endocytosis and the selective lipid transfer29–33, to date SR-BI is still considered the most responsible for 
the selective CE uptake from HDL, whereas CE intracellular movements from plasma-membrane to the 
LDs are completely unknown. Moreover, as other proteins (i.e., hepatic lipase, lipoprotein lipase) have 
been proposed to mediate HDL selective CE uptake, we cannot exclude their involvement also during 
the cell cycle34–37. To conclude, our data strongly suggest that in normal cells, the pathway leading to 
CE increase is related to the passage from quiescence to proliferation and is achieved mainly through 
CE-HDL/SR-BI/LDs pathway, which remains continuously active in cancer cells. It remains to be estab-
lished whether CE storage simply supplies cholesterol requirements in the following cycles or if it is, in 
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some way, related to the control of cell proliferation itself. Identification of the differences in delivering 
CEs in physiological and pathological proliferation by HDL would open up their use as a promising tool 
for delivering lipophilic drugs preferentially targeting cancer cells, as already suggested38,39.
Materials and Methods
Cell cultures. Stock culture of Swiss 3T3 mouse fibroblasts (ATTC, Rockville, MD) were cultured 
in DMEM medium supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, 100 μ g/
ml streptomycin, 25 mM HEPES and 2 mM L-glutamine at 37 °C in an incubator with a humidified 
atmosphere of 95% air and 5% CO2. Twice weekly, confluent cultures (about 4.0 × 104cells/cm2) were 
trypsinized and seeded at the growing concentration of 1.5 × 104cells/cm2. For analyses, fibroblasts were 
synchronised at quiescence and G0 cells were induced to G1/S entry by two ways. (i) Confluent contact-
ed-inhibited fibroblasts, were trypsinized and re-cultured at the growing concentration of 1.5 × 104cells/
cm2, cells were harvested at 0, 24, 48 and 96 h after dilution. To visualise, in the same culture, possible 
differences determined by proliferative stimulus exerted by contact loss, we have utilised the scratch 
wound assay. Specifically, the confluent cell layer was scraped along a middle line using a pipette tip 
as previously described13, and cells in the scratching line were observed after 24 h. (ii) In sub-confluent 
cultures medium was removed, and cells were made quiescent by culturing them in presence of serum-
free medium for further 24 h (SDC). Afterwards, fibroblast entry into cell cycle was induced with FCS 
(10%), HDL (100 μ g/ml; Bioquote Ltd., York, UK) or PDGF-BB (25 ng/ml; Sigma-Aldrich, Milan, Italy) 
and harvested after an additional 24 h.
Determination of cholesterol esterification and triglyceride synthesis from [14C]-oleate. For 
measuring CE and triglyceride (TG) synthesis, cells were grown in 25 cm2 flasks and harvested at the 
indicated times. Cells were incubated for 4 h in medium containing [14C]-oleate bound to bovine serum 
albumin (BSA). To prepare the oleate-BSA complex, 3.7 MBq of [14C]-oleic acid in ethanol (specific 
activity 2.035 GBq/mmol) was mixed with 1.4 mg KOH and the ethanol evaporated. PBS (1.5 ml) without 
Ca2+ and Mg2+, containing 4.24 mg BSA (fatty acid-free) was added and the mixture shaken vigorously. 
This solution was added to each well for a final concentration of 74 KBq/ml. After incubation, trypsinized 
cells were washed with ice-cold PBS and lipids extracted with acetone. Neutral lipids were separated by 
TLC as below, and incorporation of [14C]-oleate into CEs and TGs was measured40. An aliquot of cell 
lysate was processed for protein content41.
Determination of cholesterol synthesis from [14C]-acetate. Cholesterol synthesis was evaluated 
at the indicated times after diluting cells at 1.5 × 104cells/cm2 (exponential growth) up to the concentra-
tion of about 4.0 × 104cells/cm2 (quiescence). To determine the rate of cholesterol synthesis, 3 h before 
the harvesting times cells were incubated with 37 KBq/ml of sodium [14C]-acetate. After incubation cells 
were separated by centrifugation and collected. Lipids were extracted with cold acetone and neutral 
lipids separated by thin layer chromatography (TLC) Kiesegel plates using a solvent system containing 
heptane/isopropylether/formic acid (60:40:2 v/v/v). As for CEs and TGs, free cholesterol (FC) bands were 
identified by means of comparison with standards running simultaneously with samples, and visualised 
using iodine vapor7. For counting, bands were excised and added directly to counting vials containing 
Ultima Gold. All incubations were carried out in triplicate and the results of individual experiments are 
given as mean values variation between triplicates was less than 10%. All data are expressed as the rate 
of [14C]-acetate incorporation into cholesterol for μ g of protein41.
Preparation of cholesteryl [14C]-oleate HDL. Commercially available HDL (d = 1.063–1.210, 
Bioquote Ltd., York, UK) were incubated with cholesteryl [1-14C]-oleate (sp act 1.9 GBq/mmol, NEN, 
Boston, USA) according to a modified method of Terpstra et al.42. Briefly, radiolabeled cholesteryl oleate 
dissolved in toluene was evaporated under a stream of nitrogen. The tracer was resolubilised in ethanol 
and then added to a solution of HDL and lipoprotein-deficient serum (LPDS) at the concentration of 
0.05 μ Ci/μ g HDL. The mixture was incubated for 24 h at 37 °C in a shaking bath under nitrogen, and the 
[14C]-CE-HDL was isolated by density gradient ultracentrifugation (Beckman L8-M, Milan, Italy). The 
labeled HDL preparation was extensively dialysed (PBS, EDTA 1 mM, pH 7.4), protein content evaluated 
a sterile-filtered (0.45 mm, Millipore). Labeled HDLs, were added to a 10% LPDS DMEM medium at the 
concentration of 100 g/ml.
Free cholesterol and CE content in quiescent and exponentially growing fibroblasts. Total 
lipids were extracted from the cells using the method of Folch et al40. Aliquots from chloroform phase 
were dried down under vacuum and dissolved in methanol for HPLC analysis. Separation of CEs was 
carried out as described43–45 using an Agilent 1100 HPLC system (Agilent, Palo Alto, CA, USA) equipped 
with a diode array detector and mass spectrometer in line. UV and mass spectra were recorded to con-
firm the identification of HPLC peaks. In some experiments cells were exposed to commercially available 
human HDL (density range = 1.063–1.210 g/ml, containing HDL2 and HDL3, Bioquote Ltd., York, UK), 
and LDL (density range = 1.019.1.063 g/ml). Prior to use, lipoprotein homogeneity was determined by 
agarose gel electrophoresis and the integrity of the commercially purchased HDL by evaluating the CE 
oxidation state as previously described9.
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DiI-LDL binding and DiI-HDL uptake. To evaluate the uptake of CE from HDL we utilised purified 
lipoproteins labeled with the fluorescent probe 1,1′ -dioctadecyl-3,3,3′ ,3′ -tetramethyl-indocarbocyanine 
perchlorate (DiI). To compare with the other major pathway to obtain cholesterol and then CE, the binding 
of LDL was evaluated. DiI is a fluorescent dye that, when excited with wavelengths around 514 nm, shows 
an emission peak in the range of 550 nm, suitable for viewing with a common rhodamine filter8,22. In the 
present study, a modified protocol was applied. In particular, cells were seeded in 35 mm glass-bottomed 
dishes (Ibidi, Martinsried, Germany) at a concentration of 2.0 × 104cells/cm2 and incubated at 37 °C and 
5% CO2 for 24, 48 and 96 h. Subsequently, cells were washed twice with PBS and once with medium 199 
supplemented with 10 mM HEPES, pH 7.4, and incubated at 4 °C with DiI-LDL or DiI-HDL (Bioquote 
Ltd., York, UK), diluted to a concentration of 10 μ g/ml for 2 h and 1 h, respectively. All lipoprotein incu-
bations were carried out at 4 °C; at this temperature LDL bind to their receptor but internationalisation 
is prevented, giving the characteristic crown shape; HDL bind to the plasma-membrane protein SR-BI 
but only the CE component is selectively internalised. Previous experiments had shown that CE uptake is 
already present also at lower temperature (4 °C) and consistently increased at higher temperature (18 and 
37 °C)9. Following incubation cells were fixed with 4% PFA for 10 min at RT and observed. For time-lapse 
experiments, living cells were incubated for 1 h at 4 °C with DiI-HDL, then the cells were washed with 
PBS and the DiI fate has been followed for up to 1 h at RT (see movies).
LDs and plasma membrane cholesterol imaging and measurements. In order to visualise the 
reserve compartment of neutral lipids in situ (LDs), cells were cultured in 35 mm glass-bottomed dishes 
(Ibidi, Martinsried, Germany). After fixation with 4% PFA for at least 30 min, cells were washed in 
PBS and stained firstly with filipin (50 μ g/ml; Sigma-Aldrich, Milan, Italy) and finally with 300 nM Nile 
Red (9-diethylamino-5H-benzo[α]phenoxazine-5-one; Fluka, Buchs, SG, Switzerland) in PBS. Filipin 
is a fluorescent dye that specifically stains plasma membrane cholesterol, while Nile Red (NR) stains 
differentially polar lipids (i.e., phospholipids) and neutral lipids (i.e., CEs and TGs). Polar lipids display 
a red emission, while neutral lipids a green emission. Red emission was observed with 540 ± 12.5 nm 
excitation and 590 LP nm emission filters. Green emission was observed with 460 ± 25 nm excitation and 
535 ± 20 nm emission filters. Filipin was observed with 360 ± 20 excitation and 460 ± 25 emission filters. 
Filipin and Nile Red emissions were completely separated by the selected filters, so that both probes 
could be used in combination on the same cells13.
SR-BI and BrdU immunodetection in situ. For SR-BI immunodetection, cells were fixed in 4% PFA 
for 10 min, permeabilized with 0.1% Triton X-100 in PBS supplemented with 10% FBS and incubated 
overnight at 4 °C with the primary anti-SR-BI polyclonal antibody (Abcam, Cambridge, UK) followed by 
a suitable ATTO-conjugated secondary antibody (Sigma-Aldrich, Milan, Italy) for 1 h at RT. Cells were 
washed with PBS and observed. In order to evaluate the proliferation state, living cells were treated with 
10 μ M 5-bromo-2-deoxyuridine (BrdU; Sigma-Aldrich, Milan, Italy) for 6 h. BrdU is a uridine derivative 
and a structural analog of thymidine, and it can be incorporated into DNA during the synthesis (S) 
phase of the cell cycle as a substitute for thymidine, allowing visualisation by immunostaining methods. 
After treatment, cells were fixed in 4% PFA for 30 min, permeabilized with 1% Triton X-100 in PBS for 
15 min and, in order to break open the DNA structure, incubated first with 1 N HCL at 4 °C for 10 min 
and finally with 2 N HCL at RT for 30 min. Immediately after the acid washes, borate buffer (0.1 M) 
was added to the cells for 15 min at RT, followed by rinsing and washing, in PBS with 1% Triton X-100 
at RT for 15 min. Nonspecific epitopes were blocked by incubating for 2 h in 5% goat serum in PBS 
with 1% Triton X-100 and then cells were incubated overnight with anti-BrdU monoclonal primary 
antibody (DakoCytomation, Milan, Italy) followed by a suitable ATTO-conjugated secondary antibody 
(Sigma-Aldrich, Milan, Italy) at RT for 1 h. Before observation, we proceeded to counterstain nuclei with 
650 nM Hoechst 33258 (SigmaAldrich, Milan, Italy).
Microscopy and imaging. Microscope observations were performed with an Olympus IX71 inverted 
microscope (Olympus, Tokyo, Japan) fitted with a 20x/0.7 planapochromatic objective. Twelve bit-images 
were captured using a cooled CCD camera (PCO Sensicam, Kelheim, Germany), electronically coupled 
to a mechanical shutter interposed between the 100 W Hg lamp and the microscope to limit photo 
bleaching. Excitation light was attenuated with a 6 or 1.5% neutral density filter. The nominal resolution 
of images was 0.3 microns/pixel. Quantitative analysis of images was performed with the Image Pro Plus 
package (Media Cybernetics, Silver Springs, MD, USA). At least 400 cells were measured individually 
for each experimental group.
DNA cell cycle assay by FACS analysis. For DNA cell-cycle analysis 1.0 × 106 trypsinized cells 
were centrifuged at 300 g for 10 min and fixed in ethanol and stored at 2–8 °C until DNA staining. Before 
analysis, cells were washed twice in PBS and stained with 50 μ g/ml propidium iodide (Sigma-Aldrich, 
Milan, Italy) and 1 mg/ml RNAse (Roche, Monza, Italy) in PBS for 1 h at 2–8 °C. DNA content was 
measured using FACScan flow cytometer (Becton-Dickinson, Mountain View, CA, USA). The propidium 
iodide stained nuclei, excited at 488 nm with 200 mW laser power, was measured through a 620 ± 40 nm 
band-pass filter46. List mode files were analysed using CellQuest (Becton-Dickinson, Mountain View, CA, 
USA). Histograms of cell number vs linear integrated red fluorescence (proportional to DNA content) 
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were recorded for a minimum of 10000 nuclei (excluding internal standard) at flow rates no greater 
than 30 to 50 events per second. Cell-cycle analysis of the DNA histograms was performed with ModFit 
(Becton-Dickinson, Mountain View, CA, USA). The software package includes algorithms for estimat-
ing multi-cut debris and aggregates, which were subtracted in all samples prior to cell-cycle analysis as 
described elsewhere47.
DiO-HDL uptake by flow cytometry. To evaluate the uptake of CE from HDL by flow cytometry we 
utilised purified lipoproteins labeled with the fluorescent probe DiO (3,3′ -dioctadecyloxacarbocyanine). 
In the present study, a modified protocol was applied. In particular, cells were seeded at a concentration 
of 2.0 × 104cells/cm2 and incubated at 37 °C and 5% CO2 for 24, 48 and 96 h. Subsequently, cells were 
washed twice with PBS and once with medium 199 supplemented with 10 mM HEPES, pH 7.4, and incu-
bated at 4 °C with DiO-HDL (Kalen Biomedical, MD, USA), diluted to a concentration of 10 μ g/ml for 
1 h. Following incubation cells were washed with PBS, trypsinized and suddenly fixed with 4% PFA for 
10 min at RT. After fixation cells were washed and harvested for measurements. DIO-HDL fluorescence 
was observed with a BD FACS Canto II equipped with 488 ± 10 nm excitation laser and 530 ± 30 nm 
emission filters. All data were processed with BD Facsdiva 6.1.3 (Becton Dickinson, Mountain View, CA, 
USA). At least 10000 cells were evaluated for each group and each experiment was carried out at least 
twice. The data are reported as the weighted mean value of fluorescence evaluated in positive cells (P2) 
normalized to the entire population (P1 + P2).
Protein expression by western blot analysis. The cells were lysed at 4 °C in a PBS buffer con-
taining 10% SDS, 50 μ g TRIS, 1 μ M EDTA, pH 7.5, 50 μ M DTT and a protease/phosphatase inhibi-
tor cocktail, homogenised by a UP100H Compact Ultrasonic Laboratory Device (Hielscher Ultrasonic 
GmbH, Teltow, Germany). Protein content of each sample was determined by BCA (Sigma-Aldrich, 
Milan, Italy) assay48 and processed as previously described8. In particular, protein samples (30 μ g/lane) 
were separated by electrophoresis (acrylamide precast gel; Bio-Rad, Laboratories Inc., Milan, Italy) and 
transferred to nitrocellulose, 0.45 μ m pore size (Millipore, Milan, Italy) by standard electro-blotting pro-
cedure. The blots were pre-treated with a solution containing 5% non fat dried milk at 4 °C in TBST 
(50 μ M TRIS-HCl, pH 7.6, 0.15 M NaCl and 0.05% Tween-20) for at least 1 h before the addition of 
the primary antibodies (dilution range varying from 1:200 to 1:5000) for SR-BI (anti-rabbit polyclonal 
antibody), pAKT (anti rabbit polyclonal antibody), AKT (anti rabbit polyclonal antibody), pERK (anti 
goat polyclonal antibody), ERK (anti mouse monoclonal antibody) and β -actin (anti-goat polyclonal 
antibody). After an overnight incubation at 4 °C, the primary antibodies were removed and appropriate 
horseradish peroxidase-conjugated secondary antibodies were added in a dilution range of 1:2500 to 
1:10000 for at least 1 h at RT. All the antibodies were purchased by ABCAM (Cambridge, UK). Proteins 
were detected by enhanced chemiluminescence (Millipore, Milan, Italy) and by exposure to X-ray film 
(Sigma-Aldrich, Milan, Italy) for various times. Quantification of the protein bands was then accom-
plished by densitometric analyser (Image J software, NIH Bethesda, MA, USA).
Statistical analysis. Data from all experiments were analysed with GraphPad Prism software version 
5.00 for Windows (GraphPad, San Diego, CA, USA) and Statistica (StatSoft, Tulsa, OK, USA). All data 
were analysed by unpaired two-tailed t-student test or by one-/two-way ANOVA and post-hoc tests 
(Fischer’s LSD test) when required. Significance was set at p < 0.05.
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